WHO ICTRP trial
A clinical trial to study the effects of two drugs, R-TPR-023 and Avastinâ?¢ in…
CTRI/2013/05/003699 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2013/05/003699 |
|---|---|
| Public title | A clinical trial to study the effects of two drugs, R-TPR-023 and Avastinâ?¢ in patients with Metastatic colorectal cancer |
| Scientific title | Prospective, multi-centre, randomized, open-label, two-arm, parallel group, active-control, comparative clinical study to evaluate efficacy, safety and pharmacokinetics of R-TPR-023 and Avastinâ?¢ when given intravenously in patients with Metastatic colorectal cancer |
| Primary sponsor | Reliance Life sciences Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Patients with Metastatic colorectal cancer |
| Interventions | Intervention1: R-TPR-023: Dose: 5 mg/kg, Frequency: Every 2 weeks, Route of Administration: Intravenously, Duration: 3 years. Control Intervention1: Avastinâ?¢: Dose: 5 mg/kg, Frequency: Every 2 weeks, Route of Administration… |
| Registration date | May 29, 2013 |
| Target size | 105 |
| Secondary IDs | RLS/TP/2012/01; Version 1.0, Dated: 14/02/2012 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: